Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.
Bio-Techne Corp. (TECH) shares rose 2.56% to $55.21 on Wednesday, marking its third consecutive day of gains. However, the stock underperformed compared to competitors like Amgen Inc. (AMGN), which increased by 2.89%, and Charles River Laboratories (CRL), which rose by 3.26%. Bio-Techne remains 23.49% below its 52-week high of $72.16, reached on January 22nd. The overall market saw gains, with the S&P 500 up 2.51% and the Dow Jones up 2.85%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments